Identification of a Cancer Stem Cell-Related Gene Signature in Hepatocellular Carcinoma Based on Single-Cell RNA-Seq and Bulk RNA-Seq Analysis
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26072933 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Jing Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical School, Hubei Minzu University, Enshi 445000, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Neoplastic Stem Cells, Biomarkers, Tumor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guiding project of the Science and Technology Research Project of the Education Department of Hubei Province (B2022100); the Talent project of Hubei Minzu Univ…, Science and Technology Research Project of the Education Department of Hubei Province, Talent project of Hubei Minzu University.
Abstract (Originalsprache)
Cancer stem cells (CSCs) are a heterogeneous group of tumor cells that play a significant role in tumorigenesis, therapeutic resistance, and recurrence in liver hepatocellular carcinoma (LIHC). This study combines clinical data sets from The Cancer Genome Atlas (TCGA) and the International Cancer Genome Consortium (ICGC) with bulk RNA sequencing data. This study also features the GSE156625 single-cell RNA sequencing (scRNA) data set from the GEO to explore the prognostic significance of CSC biomarkers (BCSCs) in LIHC. In this research, we introduce a developed prognostic risk model that relies on nine specific BCSCs, including ADM, CCL5, CD274, DLGAP5, HOXD9, IGF1, S100A9, SOCS2, and TNFRSF11B. It was found that high-risk patients experience shorter overall survival rates when compared to low-risk patients. Additionally, the study characterized the composition of immune cells within the tumor microenvironment (TME) and revealed significant variations in gene-expression levels and mutation rates between different risk groups. The model suggests that liver cancer progression might be driven by immune evasion independent of PD-L1 and highlights the potential of the low-risk BCSC group being sensitive to various treatments. Our findings offer a promising foundation for personalized LIHC therapy and highlight the need for further experimental validation of the roles of these CSCs in disease progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical School, Hubei Minzu University, Enshi 445000, China.
- Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
ORCID-Profile: Wei Liu
Förderung
- Guiding project of the Science and Technology Research Project of the Education Department of Hubei Province (B2022100); the Talent project of Hubei Minzu Univ…
- Science and Technology Research Project of the Education Department of Hubei Province
- Talent project of Hubei Minzu University
- Hubei Minzu University Internal Research Project
- National Natural Science Foundation of China
Zitieren
APA
Wu, J., Liu, X., Huang, S., & Liu, W. (2025). Identification of a Cancer Stem Cell-Related Gene Signature in Hepatocellular Carcinoma Based on Single-Cell RNA-Seq and Bulk RNA-Seq Analysis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26072933
Vancouver
Wu J, Liu X, Huang S, Liu W. Identification of a Cancer Stem Cell-Related Gene Signature in Hepatocellular Carcinoma Based on Single-Cell RNA-Seq and Bulk RNA-Seq Analysis. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26072933
BibTeX
@article{Wu2025,
author = {Wu, Jing and Liu, Xu and Huang, Sheng and Liu, Wei},
title = {Identification of a Cancer Stem Cell-Related Gene Signature in Hepatocellular Carcinoma Based on Single-Cell RNA-Seq and Bulk RNA-Seq Analysis},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26072933}
}
EUVIMED